Safety and Activity of Flotetuzumab in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results from the COG PEPN1812 Phase 1 Trial

Adam J. Lamble, Xiaowei Liu, Charles G. Minard, Olga Militano, M. Brooke Bernhardt, Todd M. Cooper, E.A. Kolb, Erin H. Breese, Elizabeth Fox, Sarah K. Tasian, Brenda J. Weigel